Cellevolve Bio
PrivateLast Round
Seed
Nov 18, 2021
Total Funding Raised
$6M
Company Overview
Cellevolve Bio is a biotechnology company that develops and commercializes cell therapies for neglected diseases, including pediatric and rare conditions, through an integrated clinical development and commercialization platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellevolve Bio Comparables
Compare Cellevolve Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrainChild Bio, Inc. | 79% | |
| ElevateBio | 69% | |
| Kincell Bio | 66% | |
Cellevolve Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 18, 2021 |
Cellevolve Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hibiscus BioVentures | Seed |
| Catalytic Impact Foundation | Seed |
| Jumpstart Nova | Seed |
| Boxcar Partners | Seed |
Cellevolve Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cellevolve Bio's valuation, stock price, and market status.